Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1513/AnnalsATS.201807-451LE | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to "Comment on 'Prognostic Impact of the Cholangiolar Component in Combined Hepatocellular-Cholangiocarcinoma: Insights From a Western Single-Center Study'".
J Surg Oncol
December 2024
Departament of Gastroenterology, Digestive Surgery Division, Liver Surgery Unit, University of São Paulo Medical School, São Paulo, Brazil.
Reply: Can plasma FSTL-1 levels serve as a reliable biomarker for advanced fibrosis?
Hepatology
December 2024
Hepatobiliary Center of The First Affiliated Hospital, Nanjing Medical University; Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, Jiangsu.
Reply to the commentary on "Blockade of thromboxane A2 signaling attenuates ethanol-induced myocardial inflammatory response in mice".
Alcohol Clin Exp Res (Hoboken)
December 2024
Division of Diabetes, Endocrinology, and Metabolism, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
[Retracted] A disintegrin and metalloprotease 17 promotes microglial cell survival via epidermal growth factor receptor signalling following spinal cord injury.
Mol Med Rep
February 2025
Department of Orthopedics, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, Liaoning 121001, P.R. China.
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the cell apoptotic data shown in Fig. 3A, the flow cytometric (FCM) data in Fig. 3B on p.
View Article and Find Full Text PDFReply to the Editor: Reassessing margin standards in breast-conserving therapy.
Eur J Surg Oncol
November 2024
Edinburgh Breast Unit, and Edinburgh University and Western General Hospital Edinburgh, UK.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!